Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice

Langfelder, Peter, Cantle, Jeffrey P, Chatzopoulou, Doxa, Wang, Nan, Gao, Fuying, Al-Ramahi, Ismael, Lu, Xiao-Hong, Ramos, Eliana Marisa +14 more·2016·Nature Neuroscience

Cited by (408)

Items 101–200 of 408

  1. Transcriptional correlates of the pathological phenotype in a Huntington’s disease mouse model
    Andrea Gallardo-Orihuela, Irati Hervás-Corpión, Carmen Hierro‐Bujalance, Daniel Sanchez-Sotano, Gema Jiménez‐Gómez, Francisco Mora‐López, Antonio Campos‐Caro, Mónica Garcı́a-Alloza, Luis Miguel Valor · 2019 · Scientific Reports
  2. The role of the ZEB1–neuroinflammation axis in CNS disorders
    Elham Poonaki, Ulf D. Kahlert, Sven Guenther Meuth, Ali Gorji · 2022 · Journal of Neuroinflammation
  3. Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
    Carlos Estevez‐Fraga, André Altmann, Christopher S Parker, Rachael I. Scahill, Beatrice Costa, Zhongbo Chen, Claudia Manzoni, Angeliki Zarkali, Alexandra Dürr, Raymund A.C. Roos et al. · 2023 · Brain
  4. Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models
    Meng Yu, Yuhua Fu, Yijian Liang, Haikun Song, Yao Yao, Peng Wu, Yuwei Yao, Yuyin Pan, Xue Wen, Lixiang Ma et al. · 2017 · Cell Research
  5. Proteomic Analysis of Huntington’s Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets
    Kizito‐Tshitoko Tshilenge, Carlos Galicia Aguirre, Joanna Bons, Akos A. Gerencser, Nathan Basisty, Sicheng Song, Jacob Rose, Alejandro Lopez‐Ramirez, Swati B. Naphade, Ashley Loureiro et al. · 2023 · Molecular & Cellular Proteomics
  6. Integrated systems analysis reveals conserved gene networks underlying response to spinal cord injury
    Jordan W. Squair, Seth Tigchelaar, Kyung‐Mee Moon, Jie Liu, Wolfram Tetzlaff, Brian K. Kwon, Andrei V. Krassioukov, Christopher Roy West, Leonard J. Foster, Michael A. Skinnider · 2018 · eLife
  7. Molecular pathway analysis towards understanding tissue vulnerability in spinocerebellar ataxia type 1
    Terri M. Driessen, Jong Seo Lee, Janghoo Lim · 2018 · eLife
  8. Lack of RAN-mediated toxicity in Huntington’s disease knock-in mice
    Su Yang, Huiming Yang, Luoxiu Huang, Luxiao Chen, Zhaohui Steve Qin, Shihua Li, Xiao‐Jiang Li · 2020 · Proceedings of the National Academy of Sciences
  9. Epigenetic regulation in Huntington's disease
    Jae Wook Hyeon, Albert H. Kim, Hiroko Yano · 2021 · Neurochemistry International
  10. Quantitative Proteomic Analysis Reveals Similarities between Huntington’s Disease (HD) and Huntington’s Disease-Like 2 (HDL2) Human Brains
    Tamara Ratovitski, Raghothama Chaerkady, Kai Kammers, Jacqueline C. Stewart, Anialak Zavala, Olga Pletniková, Juan Carlos Troncoso, Dobrila D. Rudnicki, Russell L. Margolis, Robert Norman Cole et al. · 2016 · Journal of Proteome Research
  11. Comparison of sirtuin 3 levels in ALS and Huntington's disease-differential effects in human tissue samples vs. transgenic mouse models
    Buck, Eva, Bayer, Hanna, Lindenberg, Katrin S., Hanselmann, Johannes, Pasquarelli, Noemi, Ludolph, Albert C., Weydt, Patrick, Witting, Anke · 2017 · Frontiers in Molecular Neuroscience
  12. Transcriptional Dysregulation in Huntington’s Disease: The Role in Pathogenesis and Potency for Pharmacological Targeting
    Aleksandra Pogoda-Wesołowska, Natalia Chmielewska, Piotr Maciejak, Janusz Szyndler · 2020 · Current Medicinal Chemistry
  13. Molecular Mechanisms Underlying Muscle Wasting in Huntington’s Disease
    Manuela Bozzi, Francesca Sciandra · 2020 · International Journal of Molecular Sciences
  14. Huntington’s disease mouse models: unraveling the pathology caused by CAG repeat expansion
    Julia Kaye, Terry Reisine, Steven M. Finkbeiner · 2021 · Faculty Reviews
  15. Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease
    Uri Nimrod Ramírez-Jarquín, Manish Sharma, Wuyue Zhou, Neelam Shahani, Srinivasa Subramaniam · 2022 · Proceedings of the National Academy of Sciences
  16. Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches
    Edward J. Smith, Kirupa Sathasivam, Christian Landles, Georgina F Osborne, Michael Atwood Mason, Casandra Gomez-Paredes, Bridget A. Taxy, Rebecca E Milton, Anne Ast, Franziska Schindler et al. · 2022 · Brain Communications
  17. HttQ111/+ Huntington’s Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction
    Marina V. Kovalenko, Austen J. Milnerwood, James V. Giordano, Jason St. Claire, Jolene R. Guide, Mary Stromberg, Tammy Gillis, Ellen Sapp, Marian DiFiglia, Marcy E. MacDonald et al. · 2018 · Journal of Huntington s Disease
  18. Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington’s disease mice
    Rafael Alcalá‐Vida, Jonathan Séguin, Caroline Lotz, Anne Marie Molitor, Ibai Irastorza-Azcárate, Ali Awada, Nezih Karasu, Aurélie Bombardier, Brigitte Cosquer, José Luis Gómez-Skármeta et al. · 2021 · Nature Communications
  19. Conformation Polymorphism of Polyglutamine Proteins
    Xinran Feng, Shouqing Luo, Boxun Lu · 2018 · Trends in Biochemical Sciences
  20. Protein changes in synaptosomes of Huntington's disease knock-in mice are dependent on age and brain region
    Ellen Sapp, Connor Seeley, Maria Iuliano, Elizabeth Weisman, Petr Vodička, Marian DiFiglia, Kimberly B. Kegel-Gleason · 2020 · Neurobiology of Disease
  21. Neuronal and astrocytic contributions to Huntington’s disease dissected with zinc finger protein transcriptional repressors
    Mohitkumar R. Gangwani, Joselyn S. Soto, Yasaman Jami‐Alahmadi, Srushti Tiwari, Riki Kawaguchi, James Akira Wohlschlegel, Baljit S. Khakh · 2023 · Cell Reports
  22. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington’s Disease Knock-In Mice
    João Luís Neto, Jong‐Min Lee, Ali Afridi, Tammy Gillis, Jolene R. Guide, Stephani Dempsey, Brenda Lager, Isabel da Conceição Moreira Pereira Alonso, Vanessa Chantal Wheeler, Ricardo Mouro Pinto · 2016 · Genetics
  23. A Generative Adversarial Network Model for Disease Gene Prediction With RNA-seq Data
    Xue Jiang, Jingjing Zhao, Wei Qian, Weichen Song, Guan Ning Lin · 2020 · IEEE Access
  24. D1R- and D2R-Medium-Sized Spiny Neurons Diversity: Insights Into Striatal Vulnerability to Huntington’s Disease Mutation
    Guendalina Bergonzoni, Jessica Döring, Marta Biagioli · 2021 · Frontiers in Cellular Neuroscience
  25. Development of a ligand for in vivo imaging of mutant huntingtin in Huntington’s disease
    Daniele Bertoglio, Jonathan Bard, Manuela Heßmann, Longbin Liu, Annette Gärtner, Stef De Lombaerde, Britta Huscher, Franziska Zajicek, Alan Miranda, Finn Peters et al. · 2022 · Science Translational Medicine
  26. Differential Alteration in Expression of Striatal GABAAR Subunits in Mouse Models of Huntington’s Disease
    Zhuowei Du, Margot Tertrais, Gilles Courtand, Thierry Lesté-Lasserre, Laura Cardoit, F. Masmejean, Christophe Halgand, Yoon H. Cho, Maurice Garret · 2017 · Frontiers in Molecular Neuroscience
  27. Unsupervised discovery of phenotype-specific multi-omics networks
    W. Jenny Shi, Yonghua Zhuang, Pamela H. Russell, Brian D. Hobbs, Margaret M. Parker, Peter J. Castaldi, Pratyaydipta Rudra, Brian E. Vestal, Craig P. Hersh, Laura M. Saba et al. · 2019 · Bioinformatics
  28. CTIP2-Regulated Reduction in PKA-Dependent DARPP32 Phosphorylation in Human Medium Spiny Neurons: Implications for Huntington Disease
    Marija Fjodorova, Morgane Louessard, Zongze Li, Daniel Cabezas de la Fuente, Emma Dyke, Simon P. Brooks, Anselme L. Perrier, Meng Li · 2019 · Stem Cell Reports
  29. Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease
    Galen E.B. Wright, Nicholas S. Caron, Bernard Ng, Lorenzo L. Casal, William Casazza, Xiaohong Xu, Jolene Ooi, Mahmoud A. Pouladi, Sara Mostafavi, Colin J. Ross et al. · 2020 · Human Molecular Genetics
  30. Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis
    Benjamin L. Smarr, Tamara Cutler, Dawn H. Loh, Takashi Kudo, Dika A. Kuljis, Lance J. Kriegsfeld, Cristina Antonella Ghiani, Christopher Scott Colwell · 2019 · Journal of Neuroscience Research
  31. Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
    Aynur Soenmez, Rasem Mustafa, Salome T. Ryll, Francesca Tuorto, Ludivine Wacheul, Donatella Ponti, Christian Litke, Tanja Hering, Kerstin Kojer, Jenniver Koch et al. · 2021 · Cell Death and Disease
  32. CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Dahyun Yu, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Acta Neuropathologica Communications
  33. Genetically-directed Sparse Neuronal Labeling in BAC Transgenic Mice through Mononucleotide Repeat Frameshift
    Xiao‐Hong Lu, X. William Yang · 2017 · Scientific Reports
  34. Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington's disease
    Sonal Agrawal, Jonathan H. Fox · 2019 · Mitochondrion
  35. Single-nuclei transcriptome analysis of Huntington disease iPSC and mouse astrocytes implicates maturation and functional deficits
    Andrea M. Reyes-Ortiz, Edsel M. Abud, Mara S. Burns, Jie Wu, Sarah J. Hernandez, Nicolette R. McClure, Keona Q. Wang, Corey J. Schulz, Ricardo Miramontes, Alice Lau et al. · 2022 · iScience
  36. Modeling Variability in the Progression of Huntington's Disease A Novel Modeling Approach Applied to Structural Imaging Markers from TRACK‐HD
    JH Warner, Cristina Sampaio · 2016 · CPT Pharmacometrics & Systems Pharmacology
  37. Mutant huntingtin protein decreases with CAG repeat expansion: implications for therapeutics and bioassays
    Christian Landles, Georgina F Osborne, Jemima M Phillips, María Cañibano-Pico, Iulia M Nita, Nadira S. Ali, Konstantin Bobkov, Jonathan R. Greene, Kirupa Sathasivam, Gillian P. Bates · 2024 · Brain Communications
  38. HDinHD: A Rich Data Portal for Huntington’s Disease Research
    Jeff Aaronson, Vahri Beaumont, Richard A. Blevins, Viktoria Andreeva, Irina Murasheva, Anastasia Shneyderman, Kabenla Armah, Rob Gill, Jian Chen, Jim Rosinski et al. · 2021 · Journal of Huntington s Disease
  39. Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease
    Raleigh M. Linville, Renée F. Nerenberg, Gabrielle N. Grifno, Diego Arevalo, Zhaobin Guo, Peter C. Searson · 2022 · Fluids and Barriers of the CNS
  40. MiR-190a potentially ameliorates postoperative cognitive dysfunction by regulating Tiam1
    Qiang Liu, Aisheng Hou, Yongyi Zhang, Ying Guo, Jingjing Li, Yinghao Yao, Kaimeng Niu, Hao Li, Yunlong Ma, Jiangbei Cao · 2019 · BMC Genomics
  41. New label-free methods for protein relative quantification applied to the investigation of an animal model of Huntington Disease
    Flora Cozzolino, Alfredo Landolfi, Ilaria Iacobucci, Vittoria Monaco, Marianna Caterino, Simona Celentano, Chiara Zuccato, Elena F. Cattaneo, Maria Monti · 2020 · PLoS ONE
  42. Huntington’s disease brain-derived small RNAs recapitulate associated neuropathology in mice
    Jordi Creus‐Muncunill, Anna Guisado-Corcoll, Veronica Venturi, Lorena Pantano, Geòrgia Escaramís, Marta García de Herreros, Maria Solaguren‐Beascoa, Ana Gámez‐Valero, Cristina Navarrete, Mercè Masana et al. · 2021 · Acta Neuropathologica
  43. A meta-analysis of transcriptomic profiles of Huntington’s disease patients
    Manuel Seefelder, Stefan Kochanek · 2021 · PLoS ONE
  44. Environmental stimulation in Huntington disease patients and animal models
    Arianna Novati, Huu Phuc Nguyen, Julia Maria Schulze-Hentrich · 2022 · Neurobiology of Disease
  45. Sphingolipids and impaired hypoxic stress responses in Huntington disease
    Johannes Burtscher, Giuseppe Pepe, Niran Maharjan, Nathan Riguet, Alba Di Pardo, Vittorio Maglione, Grégoire Paul Millet · 2023 · Progress in Lipid Research
  46. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease
    Anto Sam Crosslee Louis Sam Titus, Tanzeen Yusuff, Marlène Cassar, Elizabeth A. Thomas, Doris Kretzschmar, Santosh R. D’Mello · 2017 · Journal of Neuroscience
  47. Tau mRNA 3′UTR-to-CDS ratio is increased in Alzheimer disease
    Vega García‐Escudero, Ricardo Gargini, Patricia Martín-Maestro, Esther García, Ramón García‐Escudero, Jesús Ávila · 2017 · Neuroscience Letters
  48. Mapping brain gene coexpression in daytime transcriptomes unveils diurnal molecular networks and deciphers perturbation gene signatures
    Nan Wang, Peter Langfelder, Matthew Stricos, Lalini Ramanathan, Jeffrey Richman, Raymond Vaca, Mary Plascencia, Xiaofeng Gu, Shasha Zhang, Katherine T. Tamai et al. · 2022 · Neuron
  49. Widespread dysregulation of mRNA splicing implicates RNA processing in the development and progression of Huntington's disease
    Vincent Tano, Kagistia Hana Utami, Nur Amirah Binte Mohammad Yusof, Jocelyn Bégin, Willy Wei Li Tan, Mahmoud A. Pouladi, Sarah R. Langley · 2023 · EBioMedicine
  50. Systems Genetic Analyses Highlight a TGFβ-FOXO3 Dependent Striatal Astrocyte Network Conserved across Species and Associated with Stress, Sleep, and Huntington’s Disease
    Joseph R. Scarpa, Peng Jiang, Bojan Losic, Ben Readhead, Vance Gao, Joel T. Dudley, Martha Hotz Vitaterna, Fred William Turek, Andrew Kasarskis · 2016 · PLoS Genetics
  51. Complementarity of gluCEST and 1H‐MRS for the study of mouse models of Huntington's disease
    Jérémy Pépin, Lucie de Longprez, Fabrice Trovero, Emmanuel Brouillet, Julien Valette, Julien Flament · 2020 · NMR in Biomedicine
  52. FOXO3 targets are reprogrammed as Huntington's disease neural cells and striatal neurons face senescence with p16INK4a increase
    Jessica Voisin, Francesca Farina, Swati B. Naphade, Morgane Fontaine, Kizito‐Tshitoko Tshilenge, Carlos Galicia Aguirre, Alejandro Lopez‐Ramirez, Julia Dancourt, Aurélie Ginisty, Satish Sasidharan Nair et al. · 2020 · Aging Cell
  53. Modelling the Human Blood–Brain Barrier in Huntington Disease
    Domenico Vignone, Odalys Gonzalez Paz, Ivan Fini, Antonella Cellucci, Giulio Auciello, Maria Rosaria Battista, Isabelle Gloaguen, Silvia Fortuni, Cristina Cariulo, Vinod K. Khetarpal et al. · 2022 · International Journal of Molecular Sciences
  54. CAG repeat expansion in the Huntington’s disease gene shapes linear and circular RNAs biogenesis
    Dilara Ayyildiz, Alan Monziani, Takshashila Tripathi, Jessica Döring, Guendalina Bergonzoni, Emanuela Kerschbamer, Francesca Di Leva, Elia Pennati, Luisa Donini, Marina V. Kovalenko et al. · 2023 · PLoS Genetics
  55. Netboost: Boosting-Supported Network Analysis Improves High-Dimensional Omics Prediction in Acute Myeloid Leukemia and Huntington’s Disease
    Pascal Schlosser, Jochen Knaus, Maximilian Schmutz, Konstanze Döhner, Christoph Plass, Lars Bullinger, Rainer Claus, Harald Binder, Michael Lübbert, Martin Christian Schumacher · 2020 · IEEE Transactions on Computational Biology and Bioinformatics
  56. Striatal insights: a cellular and molecular perspective on repetitive behaviors in pathology
    Charlotte Lauren Burton, Alessandra Longaretti, Andjela Zlatanovic, Guilherme M. Gomes, Raffaella Tonini · 2024 · Frontiers in Cellular Neuroscience
  57. Genome Editing in Neurosciences
    Rudolf Jaenisch, Fred H. Gage, Feng Zhang · 2017 · Research and perspectives in neurosciences
  58. ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington’s disease
    Flora Cozzolino, Elena Vezzoli, Cristina Cheroni, Dario Besusso, Paola Conforti, Marta Valenza, Ilaria Iacobucci, Vittoria Monaco, Giulia Birolini, Mauro Bombaci et al. · 2021 · Human Molecular Genetics
  59. Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum
    Maria Iuliano, Connor Seeley, Ellen Sapp, Erin L. Jones, Callie Martin, Xueyi Li, Marian DiFiglia, Kimberly B. Kegel-Gleason · 2021 · Frontiers in Synaptic Neuroscience
  60. A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases
    Sean L. Johnson, Wei-Ling Tsou, Matthew V. Prifti, A. L. Harris, Sokol V. Todi · 2022 · Frontiers in Molecular Neuroscience
  61. Identify Huntington’s disease associated genes based on restricted Boltzmann machine with RNA-seq data
    Xue Jiang, Han Zhang, Feng Duan, Xiongwen Quan · 2017 · BMC Bioinformatics
  62. Accelerated epigenetic aging in Huntington’s disease involves polycomb repressive complex 1
    Baptiste Brulé, Rafael Alcalá‐Vida, Noémie Penaud, Jil Scuto, Coline Mounier, Jonathan Séguin, Sina Vincent Khodaverdian, Brigitte Cosquer, Étienne Birmelé, Stéphanie Le Gras et al. · 2025 · Nature Communications
  63. Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration
    Rafael Alcalá‐Vida, Ali Awada, Anne‐Laurence Boutillier, Karine Mérienne · 2020 · Neurobiology of Disease
  64. Dysfunction of cAMP–Protein Kinase A–Calcium Signaling Axis in Striatal Medium Spiny Neurons: A Role in Schizophrenia and Huntington’s Disease Neuropathology
    Marija Fjodorova, Zoe Noakes, Daniel Cabezas de la Fuente, Adam C. Errington, Meng Li · 2022 · Biological Psychiatry Global Open Science
  65. Benefits of global mutant huntingtin lowering diminish over time in a Huntington’s disease mouse model
    Deanna M. Marchionini, Jeh-Ping Liu, Alberto Ambesi‐Impiombato, Kimberly Kerker, Kim Cirillo, Mukesh Bansal, Rich Mushlin, Daniela Brunner, Sylvie Ramboz, Mei Yee Kwan et al. · 2022 · JCI Insight
  66. The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice
    Marc Espina, Nadia Di Franco, Martina Brañas-Navarro, Irene Rodríguez-Navarro, Verónica Brito, Laura López-Molina, Carlos Costas‐Insua, Manuel Guzmán, Sílvia Ginés · 2023 · Neurobiology of Disease
  67. Nuclear pore dysfunction and disease: a complex opportunity
    Charlotte M. Fare, Jeffrey D. Rothstein · 2024 · Nucleus
  68. Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111/+ model of Huntington’s disease
    Robert M. Bragg, Sydney R. Coffey, Rory M. Weston, Seth A. Ament, Jeffrey P. Cantle, Shawn Minnig, Cory C. Funk, Dominic D. Shuttleworth, Emily L. Woods, Bonnie R. Sullivan et al. · 2017 · Scientific Reports
  69. Flexible Non-Negative Matrix Factorization to Unravel Disease-Related Genes
    Xue Jiang, Han Zhang, Zhao Zhang, Xiongwen Quan · 2018 · IEEE Transactions on Computational Biology and Bioinformatics
  70. The role of Twist1 in mutant huntingtin–induced transcriptional alterations and neurotoxicity
    Yanchun Pan, Ying Zhu, Wei Yang, Eric Tycksen, Shaopeng Liu, John Palucki, Linjian Zhu, Yo Sasaki, Mukesh Kumar Sharma, Albert H. Kim et al. · 2018 · Journal of Biological Chemistry
  71. RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington’s disease models
    Yingqi Lin, Caijuan Li, Yizhi Chen, Jiale Gao, Jiawei Li, Chunhui Huang, Zhaoming Liu, Wei Wang, Xiao Zheng, Xichen Song et al. · 2025 · Molecular Neurodegeneration
  72. Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice
    Marina V. Kovalenko, Serkan Erdin, Marissa A Andrew, Jason St. Claire, Melissa Shaughnessey, Leroy Hubert, João Luís Neto, Alexei Stortchevoi, Daniel M. Fass, Ricardo Mouro Pinto et al. · 2020 · eLife
  73. Dietary ketosis improves circadian dysfunction as well as motor symptoms in the BACHD mouse model of Huntington’s disease
    Daniel S. Whittaker, Katherine T. Tamai, Raj S. Bains, Sophia Anne Marie B Villanueva, Shu Hon Christopher Luk, Derek Dell’Angelica, Gene D. Block, Cristina Antonella Ghiani, Christopher Scott Colwell · 2022 · Frontiers in Nutrition
  74. Tumor Suppressor p53 Regulates Heat Shock Factor 1 Protein Degradation in Huntington's Disease
    Rachel H. Mansky, Erin A. Greguske, Dahyun Yu, Nicole Zarate, Taylor A. Intihar, Wei Tsai, Taylor G. Brown, Mackenzie N. Thayer, Kompal Kumar, Rocío Gómez‐Pastor · 2022 · Cell Reports
  75. TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration
    Jordi Creus‐Muncunill, Jean‐Vianney Haure‐Mirande, Daniele Mattei, Joanna Bons, Angie V. Ramirez Jimenez, B. Wade Hamilton, Chuhyon Corwin, Sarah Chowdhury, Birgit Schilling, Lisa Ellerby et al. · 2024 · Journal of Neuroinflammation
  76. Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease
    Marina Herrero‐Lorenzo, Jesús Pérez‐Pérez, Geòrgia Escaramís, Saül Martínez‐Horta, Rocío Pérez‐González, Elisa Rivas‐Asensio, Jaime Kulisevsky, Ana Gámez‐Valero, Eulàlia Martı́ · 2024 · Journal of Extracellular Vesicles
  77. Enhanced striatopallidal gamma‐aminobutyric acid (GABA)A receptor transmission in mouse models of huntington's disease
    Tamara Perez‐Rosello, Simon Gelman, Geoffrey C. Tombaugh, Roger Cachope, Vahri Beaumont, Dalton James Surmeier · 2019 · Movement Disorders
  78. Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington’s disease
    Sydney R. Coffey, Robert M. Bragg, Shawn Minnig, Seth A. Ament, Jeffrey P. Cantle, Anne Glickenhaus, Daniel Shelnut, José M. Carrillo, Dominic D. Shuttleworth, Julie-Anne Rodier et al. · 2017 · PLoS ONE
  79. Adenosine‐to‐Inosine RNA Editing in Mouse and Human Brain Proteomes
    Lev I. Levitsky, Anna A. Kliuchnikova, Ksenia G. Kuznetsova, Dmitry S. Karpov, Mark V. Ivanov, Mikhail A. Pyatnitskiy, Olga V. Kalinina, Mikhail V. Gorshkov, Sergei A. Moshkovskii · 2019 · PROTEOMICS
  80. Analysis of LINE1 Retrotransposons in Huntington’s Disease
    Lavinia Floreani, Federico Ansaloni, Damiano Mangoni, Elena Agostoni, Remo Sanges, Francesca Persichetti, Stefano Gustincich · 2022 · Frontiers in Cellular Neuroscience
  81. Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
    Sergey V. Lobanov, Branduff McAllister, Mia McDade‐Kumar, G. Bernhard Landwehrmeyer, Michael Orth, Anne Rosser, REGISTRY Investigators of the European Huntington’s disease network, Jane S. Paulsen, PREDICT-HD Investigators of the Huntington Study Group, Jong‐Min Lee et al. · 2022 · npj Genomic Medicine
  82. Landscape of immune cell gene expression is unique in predominantly WHO grade 1 skull base meningiomas when compared to convexity
    Zsolt E. Zador, Alexander Landry, Michael Balas, Michael D. Cusimano · 2020 · Scientific Reports
  83. Unbiased identification of novel transcription factors in striatal compartmentation and striosome maturation
    Maria‐Daniela Cirnaru, Sicheng Song, Kizito‐Tshitoko Tshilenge, Chuhyon Corwin, Justyna Mleczko, Carlos Galicia Aguirre, Houda Benlhabib, Jaroslav M. Bendl, Pasha Apontes, John F. Fullard et al. · 2021 · eLife
  84. Expression analysis of Huntington disease mouse models reveals robust striatum disease signatures
    John C. Obenauer, Jian Chen, Viktoria Andreeva, Jeffrey S. Aaronson, Ramee Lee, Andrea Caricasole, Jim Rosinski · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington’s disease
    Foteini Paraskevopoulou, Poorya Parvizi, Gökçe Senger, Nurcan Tunçbağ, Christian Rosenmund, Ferah Yildirim · 2021 · Proceedings of the National Academy of Sciences
  86. Disease-related Huntingtin seeding activities in cerebrospinal fluids of Huntington’s disease patients
    C. Y. Daniel Lee, Nan Wang, Koning Shen, Matthew Stricos, Peter Langfelder, Kristina H. Cheon, Etty Paola Cortes, Harry V. Vinters, Jean Paul Vonsattel, Nancy Sabin Wexler et al. · 2020 · Scientific Reports
  87. Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets
    Marta Daniela Costa, Patrı́cia Maciel · 2022 · Cellular and Molecular Life Sciences
  88. Huntington’s Disease: Nuclear Gatekeepers Under Attack
    Matthew B. Veldman, X. William Yang · 2017 · Neuron
  89. Inhibition of p38 Mitogen–Activated Protein Kinase Ameliorates HAP40 Depletion–Induced Toxicity and Proteasomal Defect in Huntington’s Disease Model
    Zih-Ning Huang, Jie-Mao Chen, Liang-Ching Huang, Yi-Hsuan Fang, Lu‐Shiun Her · 2021 · Molecular Neurobiology
  90. Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C
    Peng, Chaohua, Zhu, Gaochun, Liu, Xiangqian, Li, He · 2018 · Neuroscience Bulletin
  91. HSF1 and Its Role in Huntington’s Disease Pathology
    Hyuck Kim, Rocío Gómez‐Pastor · 2022 · Advances in experimental medicine and biology
  92. Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington’s disease mice and innervate the striatum
    Sandra M. Holley, Jack C. Reidling, Carlos Cepeda, Jie Wu, Ryan G. Lim, Alice Lau, Cindy Moore, Ricardo Miramontes, Brian Fury, Iliana Orellana et al. · 2023 · Molecular Therapy
  93. HD and SCA1: Tales from two 30-year journeys since gene discovery
    Leslie Michels Thompson, Harry T. Orr · 2023 · Neuron
  94. Potential molecular consequences of transgene integration: The R6/2 mouse example
    Jessie C. Jacobsen, Serkan Erdin, Colby Chiang, Carrie Hanscom, Renée R. Handley, Douglas Barker, Alexei Stortchevoi, Ian Blumenthal, Suzanne J. Reid, Russell G. Snell et al. · 2017 · Scientific Reports
  95. Co-expression Patterns between ATN1 and ATXN2 Coincide with Brain Regions Affected in Huntington’s Disease
    Arlin Keo, N. Ahmad Aziz, Oleh Dzyubachyk, Jeroen van der Grond, Willeke van Roon‐Mom, Boudewijn P. F. Lelieveldt, Marcel J. T. Reinders, Ahmed Essam Mahfouz · 2017 · Frontiers in Molecular Neuroscience
  96. Workflow for Rapidly Extracting Biological Insights from Complex, Multicondition Proteomics Experiments with WGCNA and PloGO2
    Jemma X. Wu, Dana Pascovici, Yunqi Wu, Adam K. Walker, Mehdi Mirzaei · 2020 · Journal of Proteome Research
  97. Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegeneration
    Paula Dietrich, Shanta Alli, Megan K. Mulligan, Rachel Cox, David George Ashbrook, Robert W. Williams, Ioannis Dragatsis · 2021 · Neurobiology of Disease
  98. Systems-level analysis of peripheral blood gene expression in dementia patients reveals an innate immune response shared across multiple disorders
    Daniel C. Nachun, EM Ramos, A Karydas, D Dokuru, F Gao, Z Yang, V Van Berlo, R Sears, J Kramer, Adam L. Boxer et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Retinoic acid receptor beta protects striatopallidal medium spiny neurons from mitochondrial dysfunction and neurodegeneration
    Marion Ciancia, Monika Rataj-Baniowska, Nicolas Zinter, Vito Antonio Baldassarro, Valérie Fraulob, Anne‐Laure Charles, Rosana Álvarez, Shin‐ichi Muramatsu, Ángel R. de Lera, Bernard Gény et al. · 2022 · Progress in Neurobiology
  100. Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease
    Manuel Seefelder, Fabrice A. C. Klein, G. Bernhard Landwehrmeyer, Rubén Fernández‐Busnadiego, Stefan Kochanek · 2022 · Journal of Huntington s Disease